GSK puts £145m into patent fund as Pfizer launches Viagra lawsuit

GlaxoSmithKline has put aside £145m to settle patent disputes as generic drug makers and rival pharmaceuticals giants step up the legal challenges to its intellectual property.

The UK's number one drugs group disappointed the market with its third-quarter results yesterday, citing the slide in the dollar and the launch of copycat versions of its top-selling antibiotic for lower than expected sales.

Augmentin, the antibiotic, had sales of £197m in the three months to the end of September, down 24 per cent on last year. A rival drug came on the US market in June after its maker successfully challenged GSK's patents, and has now taken more than 40 per cent of the market.

Analysts were concerned that the unusual provision of £145m against patent challenges signalled GSK was expecting more bad news.

GSK's chief executive, Jean-Pierre Garnier, said the money would mainly be used to reach out-of-court settlements.

"What generic companies are doing is throwing a lot of stuff at the wall, hoping that some of it will stick, and we will see challenges on almost every molecule. Sometimes the cost of pursuing a legal action exceeds the cost of paying this 'go away money'.

"This was a prudent topping up of the legal reserve and we are unlikely to do it every quarter unless the legal situation starts to worsen in a big way."

Some analysts thought the legal provisions were a form of "profit smoothing" after the company's earnings outstripped its guidance to the market by some way, but they underscored the extent to which GSK's fortunes are dependent on the courts. Overnight, Pfizer, the world's largest drug maker, said it had begun a US lawsuit claiming GSK's new impotence drug infringes patents on its drug, Viagra. GSK is planning to launch a rival, Levitra, next year.

Mr Garnier vowed to see off the lawsuit. "Pfizer's legal challenge is not new. They tried this approach in Europe and they failed. We are pretty confident that this will not succeed, but we will leave it to the courts. We are not changing our plans."

Eli Lilly, the US giant which also plans to launch its own rival to Viagra next year, is also being sued by Pfizer, which is hoping to protect its exclusive position in the impotence market. Viagra had sales of £1bn last year and it is estimated the global impotence market could be worth £3bn by 2006.

Eli Lilly yesterday issued another profit warning after sales of Prozac, its ground-breaking anti-depressant which lost patent protection last year, continued to slide. It has lost more than 75 per cent of its market share to generic rivals.

GSK issued its own profit warning in June when the rival Augmentin was launched, predicting a "Prozac-style" wipeout of sales. Although Augmentin's performance has not been as poor as feared, GSK yesterday stuck to its conservative guidance of "at least 10 per cent" earnings growth this year, despite the fact that earnings for the nine months so far are 15 per cent higher than last year. Pre-tax profits so far this year at up 12 per cent to £4.8bn, with £1.4bn in the third quarter, with cost savings from the merger of Glaxo Wellcome and SmithKline Beecham propelling much of the growth.

GSK shares, which have lost a third of their value in a year, were down 6 per cent to 1,247p despite confirmation of a second £4bn share buy-back programme.

The company is facing pressure in Europe, particularly in Italy, where the government is demanding lower prices, but some of its recently launched blockbusters also had lacklustre sales growth.

Start your day with The Independent, sign up for daily news emails
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

Day In a Page

Is this the future of flying: battery-powered planes made of plastic, and without flight decks?

Is this the future of flying?

Battery-powered planes made of plastic, and without flight decks
Isis are barbarians – but the Caliphate is a dream at the heart of all Muslim traditions

Isis are barbarians

but the Caliphate is an ancient Muslim ideal
The Brink's-Mat curse strikes again: three tons of stolen gold that brought only grief

Curse of Brink's Mat strikes again

Death of John 'Goldfinger' Palmer the latest killing related to 1983 heist
Greece debt crisis: 'The ministers talk to us about miracles' – why Greeks are cynical ahead of the bailout referendum

'The ministers talk to us about miracles'

Why Greeks are cynical ahead of the bailout referendum
Call of the wild: How science is learning to decode the way animals communicate

Call of the wild

How science is learning to decode the way animals communicate
Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

'The economic collapse has happened. What is at risk now is democracy...'

If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
The science of swearing: What lies behind the use of four-letter words?

The science of swearing

What lies behind the use of four-letter words?
The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

The Real Stories of Migrant Britain

Clive fled from Zimbabwe - now it won’t have him back
Africa on the menu: Three foodie friends want to popularise dishes from the continent

Africa on the menu

Three foodie friends want to popularise dishes from the hot new continent
Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

Who will fill Donna Karan's boots?

The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'
10 best statement lightbulbs

10 best statement lightbulbs

Dare to bare with some out-of-the-ordinary illumination
Wimbledon 2015: Heather Watson - 'I had Serena's poster on my wall – now I'm playing her'

Heather Watson: 'I had Serena's poster on my wall – now I'm playing her'

Briton pumped up for dream meeting with world No 1
Wimbledon 2015: Nick Bollettieri - It's time for big John Isner to produce the goods to go with his thumping serve

Nick Bollettieri's Wimbledon Files

It's time for big John Isner to produce the goods to go with his thumping serve
Dustin Brown: Who is the tennis player who knocked Rafael Nadal out of Wimbeldon 2015?

Dustin Brown

Who is the German player that knocked Nadal out of Wimbeldon 2015?
Ashes 2015: Damien Martyn - 'England are fired up again, just like in 2005...'

Damien Martyn: 'England are fired up again, just like in 2005...'

Australian veteran of that Ashes series, believes the hosts' may become unstoppable if they win the first Test